Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ABL
ABL Settles Its Dispute with Stanford University and Endorses Stanford’s HIVdb Website and Other Globally Available Research and Not-for-Profit Websites
July 10th, 2009
Advanced Biological Laboratories SA (ABL) announced that it has signed a Patent Immunity Agreement and has dismissed all claims against Stanford University, thus resolving any disputes related to ABL US patents 6.081.786, 6.188.988 and their foreign equivalents, ensuring the free access for all uses to Stanford and all the Stanford researchers and related parties. In exchange, ABL obtained free access to Stanford's US Patents RE38352, 5.856.086 and 5.631.128 and their foreign equivalents. The Patent Immunity Agreement between ABL and Stanford University involves patents from both parties. Patented products are the backbone of the global healthcare industry and most of the western world...
Source: Health Business Week (2009-07-10)
|
